Skip to main content
Veterinary Medicines

Mastiplan LC, 300mg/20mg (Cefapirin/Prednisolone), intramammary suspension for lactating cows

Authorised
  • Cefapirin
  • Prednisolone

Product identification

Medicine name:
Mastiplan LC, 300mg/20mg (Cefapirin/Prednisolone), intramammary suspension for lactating cows
MASTIPLAN LC, 300 mg/20 mg (cefapirina/prednisolone), sospensione intramammaria per bovine in lattazione
Active substance:
  • Cefapirin
  • Prednisolone
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefapirin
    300.00
    milligram(s)
    /
    1.00
    Syringe
  • Prednisolone
    20.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        4
        day
      • Milk
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Box of 1 sachet of 20 syringes and 20 cleaning towels
  • Box of 1 sachet of 4 syringes and 4 cleaning towels

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 103818
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0121/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 3/04/2023
Download
Italian (PDF)
Published on: 3/04/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."